Pseudohypoparathyroidism Type 1a
📧 Sign up to get email alerts when something new happens for Pseudohypoparathyroidism Type 1a.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Setmelanotide to Treat Obesity in a Patient With Pseudohypoparathyroidism Type 1a (PHP1a) [Phase 2]
A Phase 2 trial is evaluating setmelanotide for obesity in patients with pseudohypoparathyroidism type 1a; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old [Phase 2]
A Phase 2 clinical trial evaluating theophylline as treatment for pseudohypoparathyroidism in children aged 2-12; the study is currently act…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Theophylline for Treatment of Pseudohypoparathyroidism [Phase 2]
Phase 2 trial evaluating theophylline for treatment of pseudohypoparathyroidism; currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2025-05-28Clinical Trial Update: Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments [NA]
Connecticut Children's Medical Center is conducting a recruiting study to characterize the natural history, growth, and cognitive/behavioral…